Xenetic Biosciences Inc. (XBIO)
XBIO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.10
-0.94% on the day
Market cap
$4.9M
Nano cap
Revenue · 2025
$3.0M
+19.0% on 2024
Net income · 2025
-$2.7M
-90.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | XBIO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001534525 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $3.0M |
| Net income | -$2.7M |
| Operating income | -$2.8M |
| Net margin | -90.1% |
| Operating margin | -95.2% |
| Revenue growth | +19.0% |
| Cash | Not in SEC XBRL data |
| Total assets | $8.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B5 | 424B5 | 2025-10-14 |
| Latest annual report FORM 10-K FOR DEC 2025 AMENDMENT 1 | 10-K/A | 2026-04-24 |
| Latest quarterly / interim FORM 10-Q FOR JUN 2026 | 10-Q | 2026-08-06 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-23 |
| Latest proxy ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS | DEFA14A | 2025-12-11 |
Source: SEC EDGAR submissions feed, 484 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc. | $1.77 | -6.84% | $5.0M |
| XTLB | XTL Biopharmaceuticals Ltd. | $1.98 | +3.12% | $4.9M |
| KALA | KALA BIO Inc. | $0.2600 | -7.14% | $5.0M |
| PULM | Pulmatrix Inc. | $1.38 | -3.50% | $5.0M |
| ADXN | Addex Therapeutics Ltd | $3.01 | -0.99% | $5.1M |
| GELS | Gelteq Limited | $0.4801 | -2.06% | $5.1M |
| LNAI | Lunai Bioworks Inc. | $1.03 | -7.21% | $4.7M |
| SCNX | Scienture Holdings Inc. | $3.24 | -17.14% | $5.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier